LNTH Lantheus Holdings Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: LNTH

Price (delayed)

$102.905

Market cap

$6.7B

P/E Ratio

24.39

Dividend/share

N/A

EPS

$4.22

Enterprise value

$6.77B

?
Relative Growth: Rel. Growth: 82
Relative Strength: Rel. Strength: 84
Relative Valuation: Rel. Valuation: 53
Relative Profitability: Rel. Profitability: 87

Lantheus Holdings, Inc. is the parent company of Lantheus Medical Imaging, Inc., Progenics Pharmaceuticals, Inc. and EXINI Diagnostics AB and an established leader and fully integrated provider of innovative imaging ...

Highlights
Lantheus Holdings's EPS has increased by 22% from the previous quarter and by 15% YoY
The net income has grown by 19% from the previous quarter and by 10% YoY
The company's quick ratio has shrunk by 51% YoY but it rose by 19% QoQ
The price to earnings (P/E) is 21% more than the last 4 quarters average of 19.7
The company's gross profit fell by 5% YoY
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Website: http://investor.lantheus.com
Peers: CTSO ABT IDXX

Key stats

What are the main financial stats of LNTH

LNTH stock price

How has the Lantheus Holdings stock price performed over time
Intraday
2.65%
1 week
3.3%
1 month
17.23%
1 year
29.23%
YTD
54.63%
QTD
35.67%

Financial performance

How have Lantheus Holdings's revenue and profit performed over time
Revenue
$1.55B
Gross profit
$935.17M
Operating income
$290.09M
Net income
$279.03M
Gross margin
60.5%
Net margin
18%
LNTH's operating income is down by 36% YoY and by 7% QoQ
Lantheus Holdings's operating margin has decreased by 36% YoY and by 7% QoQ
The net income has grown by 19% from the previous quarter and by 10% YoY
The company's net margin rose by 18% QoQ and by 9% YoY

Price vs fundamentals

How does LNTH's price correlate with its fundamentals

Growth

What is Lantheus Holdings's growth rate over time

Valuation

What is Lantheus Holdings stock price valuation
LNTH P/E details
P/E
24.39
P/B
5.48
P/S
4.31
EV/EBIT
17.21
EV/EBITDA
14.33
EV/Sales
4.38
Lantheus Holdings's EPS has increased by 22% from the previous quarter and by 15% YoY
The price to earnings (P/E) is 21% more than the last 4 quarters average of 19.7
The stock's price to book (P/B) is 34% more than its last 4 quarters average of 4.0 but 11% less than its 5-year quarterly average of 6.0
The equity has increased by 11% from the previous quarter and by 4.1% YoY
The P/S is 40% higher than the last 4 quarters average of 3.0 but 4.5% lower than the 5-year quarterly average of 4.4

Efficiency

How efficient is Lantheus Holdings business performance
The return on invested capital has grown by 20% since the previous quarter
Lantheus Holdings's ROE has increased by 18% from the previous quarter and by 7% YoY
Lantheus Holdings's ROS has increased by 18% from the previous quarter and by 3.7% YoY
LNTH's return on assets is up by 15% since the previous quarter but it is down by 2.4% year-on-year

Dividends

What is LNTH's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for LNTH.

Financial health

How did Lantheus Holdings financials performed over time
The total assets is 107% more than the total liabilities
LNTH's current ratio has plunged by 51% YoY but it is up by 4.8% from the previous quarter
The company's quick ratio has shrunk by 51% YoY but it rose by 19% QoQ
The company's debt is 53% lower than its equity
The equity has increased by 11% from the previous quarter and by 4.1% YoY
Lantheus Holdings's debt to equity has decreased by 10% QoQ and by 4.1% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.